Vertex Pharmaceuticals (NASDAQ: VRTX ... and investors who get in on the stock today should benefit for years to come. Let's ...

Companies announce stock splits all the time, and so far this year a number of high profile companies have divvied up their ...

Vertex Pharmaceuticals continues to excel with strong Q3 results and promising clinical progress, but its valuation may ...

The firm owned 2,746 shares of the pharmaceutical company’s stock after selling 261 shares during the quarter. Sigma Planning Corp’s holdings in Vertex Pharmaceuticals were worth $1,277,000 at the end ...

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its target price raised by research analysts at Scotiabank from ...

Shares of Vertex Pharmaceuticals Inc. VRTX rose 1.00% to $475.08 Wednesday, on what proved to be an all-around rough trading ...

Vertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...

Vertex (VRTX) delivered earnings and revenue surprises of 6.05% and 3.62%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Vertex Pharmaceuticals (VRTX) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, VRTX broke through the 20-day moving average, which ...

Shares of Vertex Pharmaceuticals Inc. VRTX slipped 1.25% to $493.64 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 2 ...

Investors with a lot of money to spend have taken a bullish stance on Vertex Pharmaceuticals (NASDAQ:VRTX). And retail traders should know. We noticed this today when the trades showed up on ...